ZA791923B - Steroid derivatives and their use in radioimmunoassays - Google Patents

Steroid derivatives and their use in radioimmunoassays

Info

Publication number
ZA791923B
ZA791923B ZA791923A ZA791923A ZA791923B ZA 791923 B ZA791923 B ZA 791923B ZA 791923 A ZA791923 A ZA 791923A ZA 791923 A ZA791923 A ZA 791923A ZA 791923 B ZA791923 B ZA 791923B
Authority
ZA
South Africa
Prior art keywords
steroid
radioimmunoassays
steroid derivatives
dehydro
derivatives
Prior art date
Application number
ZA791923A
Other languages
English (en)
Inventor
Ravi Kannadikovilakom Varma
Kannadikovilakom Varma Ravi
Sam Tsu I Chao
Tsu I Chao Sam
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA791923B publication Critical patent/ZA791923B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Steroid Compounds (AREA)
ZA791923A 1978-05-22 1979-04-23 Steroid derivatives and their use in radioimmunoassays ZA791923B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/908,294 US4323511A (en) 1978-05-22 1978-05-22 Steroid derivatives and their use in radioimmunoassays

Publications (1)

Publication Number Publication Date
ZA791923B true ZA791923B (en) 1980-04-30

Family

ID=25425538

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA791923A ZA791923B (en) 1978-05-22 1979-04-23 Steroid derivatives and their use in radioimmunoassays

Country Status (9)

Country Link
US (1) US4323511A (fr)
EP (1) EP0005558B1 (fr)
JP (1) JPS54151959A (fr)
AT (1) ATE617T1 (fr)
AU (1) AU523079B2 (fr)
CA (1) CA1142915A (fr)
DE (1) DE2961949D1 (fr)
IL (1) IL57303A0 (fr)
ZA (1) ZA791923B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243608A (en) * 1979-05-14 1981-01-06 E. R. Squibb & Sons, Inc. 3-(4-Hydroxyphenyl)pentanedioic acid, monohydrazide, derivatives and analogs
FR2537586A1 (fr) * 1982-12-13 1984-06-15 Roussel Uclaf Derives estratrieniques radioactifs marques a l'iode, leur procede de preparation et leur application aux dosages radio-immunologiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1118409A (fr) * 1977-08-12 1982-02-16 Jack Bernstein Derives de steroides utilises dans les dosages par la methode radio-immunologique

Also Published As

Publication number Publication date
DE2961949D1 (en) 1982-03-11
US4323511A (en) 1982-04-06
CA1142915A (fr) 1983-03-15
EP0005558B1 (fr) 1982-01-27
IL57303A0 (en) 1979-09-30
AU523079B2 (en) 1982-07-08
JPS54151959A (en) 1979-11-29
ATE617T1 (de) 1982-02-15
AU4641479A (en) 1979-11-29
EP0005558A1 (fr) 1979-11-28

Similar Documents

Publication Publication Date Title
DE2960982D1 (en) Vitamin b-12 derivatives, process for their preparation and their use in radioimmunoassays
ES464193A1 (es) Procedimiento para la preparacion de espirolactonas.
DE3367774D1 (de) 5,6,7-trinor-4, 8-inter-m-phenylene prostaglandin i2 derivatives
ES508735A0 (es) "procedimiento para la preparacion de derivados de (2-halogeno-ergolinil)-n',n'-dietilurea".
GB2002385A (en) Steroid hemiesters and their use in radioimmunoassays
KR830001860A (ko) 9-아미노알킬플루오렌
AU523079B2 (en) Steroid derivatives and their use in radioimmunoassays
GR3005135T3 (fr)
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
SE7707173L (sv) Nya joderade isoftalamsyraderivat och sett att framstella desamma
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
GB2125403B (en) Fused thieno (3,2-6)thiozole-2-anure derivitives
DE3471660D1 (en) Estradiene derivatives labelled with tritium, their preparation and intermediates for their preparation, and their utilization in the study and in the determination of steroids in biological fluids
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
ES438704A1 (es) Procedimiento para preparar derivados de ergopectina.
SE7811761L (sv) 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning
GB2003480A (en) Digoxigenin derivatives
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
ES460117A1 (es) Procedimiento para la preparacion de nuevos n-bencil-aminoa-cidos que contienen azufre.
KR900003171A (ko) 방사성요오드화 벤조디아제핀 유도체
ES460297A1 (es) Un compuesto.
GB1536195A (en) 3-phenyl-sec-butylamine derivatives
SE7901316L (sv) Derivat av dehydrocykliciminsyror
ES240003A2 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE NUEVOS COMPUESTOS DE NITRoGENO HETEROCiCLICOS